Current Affairs - National - Discussion
Discussion Forum : National - Latest Current Affairs (Q.No. 4709)
4709.
Which institute received permission to carry out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety, and tolerability of antiviral drugs Umifenovir?
Answer: Option
Explanation:
CSIR-Central Drug Research Institute Lucknow received permission to carry out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety, and tolerability of antiviral drugs Umifenovir. The Phase III Clinical Trials will be carried out at King George's Medical University (KGMU), Dr. Ram Manohar Lohia Institute of Medical Sciences (RMLIMS), and ERA's Lucknow Medical College & Hospital, Lucknow.
Discussion:
Be the first person to comment on this question !
Post your comments here:
Quick links
Quantitative Aptitude
Verbal (English)
Reasoning
Programming
Interview
Placement Papers